The Resource New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book)
New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book)
Resource Information
The item New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book) represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in University of Liverpool.This item is available to borrow from 1 library branch.
Resource Information
The item New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book) represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in University of Liverpool.
This item is available to borrow from 1 library branch.
- Summary
- An essential text for cardiologists, hematologists, and pharmacologists, this third edition is a resource on current agent development technology for treating cardiovascular and thromboembolic diseases. It covers advances in scientific discovery, the growing number of patients and indications for antithrombotics, and more.
- Language
- eng
- Edition
- 3rd ed.
- Extent
- xv, 690 p.
- Contents
-
- <P><STRONG>OVERVIEW OF THE INVESTIGATION AND REGULATION AND THROMBOSIS<BR></STRONG><I>Jane EFreedman<BR></I>Overview of Hemostasis and Fibrinolysis, <I>Andrew ISchafer</I><BR>Overview of Platelet-Dependent Thrombosis, <I>Jane EFreedman, Price Blair, and Joseph Loscalzo</I><BR>Design Issues in Clinical Trials of Thrombolytic and Antithrombotic Agents, <I>Robert PGiugliano</I><BR>Pharmacogenomics and Warfarin Anticoagulation, <I>Melkon Hacobian and Samuel ZGoldhaber</I><BR>Pharmacogenomics of Platelet Inhibitors, <I>Srikanth Nagalla, Suzanne MLeal, and Paul FBray</I><BR>The Effects of Antiplatelet, Antithrombotic, and Thrombolytic Agents on Inflammation and Circulating Inflammatory Biomarkers, <I>Erdal Cavusoglu</I><BR>The Role of Platelet Function Testing in the Development of Platelet Inhibitors, <I>Alan DMichelson</I><BR>The Role of Proteomics and Transcriptomics in the Development of Antithrombotics, <I>Lisa Senzel, Dmitri VGnatenko, and Wadie FBahou<BR></I><BR><B>NEW HEPARINS, THROMBIN INHIBITORS, AND ANTITHROMBOTICS<BR></B><I>Jeffrey IWeitz<BR></I>Overview of New Anticoagulant Drugs, <I>Nahid Qushmaq and Jeffrey IWeitz</I><BR>Anticoagulants for the Treatment of Venous Thromboembolism, <I>Sam Schulman</I><BR>Anticoagulation in Acute Coronary Syndromes, <I>Simon JMcRae and John WEikelboom</I><BR>Anticoagulation in Pregnancy, <I>Shannon MBates</I><BR>Anticoagulants in Cancer, <I>Edward NLibby and Agnes YLee</I><BR>Anticoagulation in Children, <I>Paul TMonagle and Anthony K.CChan</I><BR>New Heparins: Synthetic Pentasaccharides, <I>Pieter WKamphuisen and Harry RBller</I><BR>Treatment of Heparin-Induced Thrombocytopenia, <I>Theodore EWarkentin</I><BR>Emerging Links Between Thrombosis, Inflammation, and Angiogenesis: Key Role of Heparin and Low-Molecular-Weight Heparins, <I>Shaker AMousa</I><BR>Oral Direct Factor Xa Inhibitors, <I>Alexander GGTurpie</I><BR>Direct Thrombin Inhibitors, <I>Menaka Pai and Mark ACrowther</I><BR>Modulators of the Protein C Pathway, <I>Charles TEsmon</I><BR>Factor IXa Inhibitors, <I>Richard CBecker, Mark Chan, Emily LHoward, Kristian CDBecker, and Christopher PRusconi<BR></I>Contact-Activation Pathways as Targets for New Anticoagulants, <I>David Gailani, Thomas Renne', and Andras Gruber<BR></I><BR><B>NEW ANTIPLATELET AGENTS<BR></B><I>Robert PGiugliano<BR></I>Overview of Antiplatelet Therapy, <I>Shaker AMousa, James TWillerson, and Robert PGiugliano</I><BR>Markers of Platelet Function, <I>Udaya STantry and Paul AGurbel</I><BR>Intravenous Glycoprotein IIb/IIIa Antagonists, <I>Jason NKatz and Robert AHarrington</I><BR>Inhibitors of Platelet Adhesion: VWF-GPb/IX and Collagen-GPVI<BR>Inhibitors, <I>Robert GSchaub</I><BR>Three Generations of Thienopyridines: Ticlopidine, Clopidogrel, and Prasugrel, <I>Stephen DWiviott and Elliott MAntman<BR></I>Direct PYAntagonists, <I>Marco Cattaneo</I><BR>Nitric Oxide Donors as Platelet Inhibitors, <I>Lina Badimon and Gemma Vilahur</I><BR>The Interrelationship of Thrombin and Platelets-The Protease-Activated Receptor-, <I>Rohit Bhatheja and David JMoliterno<BR></I>Other Antiplatelet Agents, <I>Catherine McGorrian and Sonia SAnand<BR></I>The Combination of Anticoagulants and Platelet Inhibitors Postcoronary Stent Implantation, <I>Hussam Hamdalla and Steven RSteinhubl<BR><BR></I><B>NEW THROMBOLYTIC AGENTS AND INDICATIONS<BR></B><I>HRoger Lijnen<BR></I>Overview of Established and New Thrombolytics, <I>HRoger Lijnen</I><BR>Thrombolysis of Deep Vein Thrombosis, <I>Peter Verhamme, Raymond Verhaeghe, and Geert Maleux</I><BR>Thrombolysis for Acute Pulmonary Embolism, <I>Gregory Piazza and Samuel ZGoldhaber</I><BR>Acute Thrombolysis in Ischemic Cerebrovascular Disease, <I>Gregory Jdel Zoppo</I><BR>Fibrinolysis for Acute Myocardial Infarction, <I>Cheuk-Kit Wong and Harvey DWhite</I><BR>Epilogue: The Evolution of Therapeutic Management of Thrombotic and Cardiovascular Disease, <I>Jane EFreedman and Joseph Loscalzo</I><BR>Index<BR></P>
- Isbn
- 9781420069242
- Label
- New therapeutic agents in thrombosis and thrombolysis
- Title
- New therapeutic agents in thrombosis and thrombolysis
- Statement of responsibility
- edited by Jane E. Freedman, Joseph Loscalzo
- Language
- eng
- Summary
- An essential text for cardiologists, hematologists, and pharmacologists, this third edition is a resource on current agent development technology for treating cardiovascular and thromboembolic diseases. It covers advances in scientific discovery, the growing number of patients and indications for antithrombotics, and more.
- Cataloging source
- DNLM/DLC
- Dewey number
- 616.13506
- Illustrations
- illustrations
- Index
- index present
- LC call number
- RC694.3
- LC item number
- .N49 2009
- Literary form
- non fiction
- Nature of contents
- bibliography
- http://library.link/vocab/relatedWorkOrContributorName
-
- Freedman, Jane E.
- Loscalzo, Joseph.
- Series statement
- Fundamental and clinical cardiology
- Series volume
- 65
- http://library.link/vocab/subjectName
-
- Thrombolytic therapy
- Fibrinolytic agents
- Thrombosis
- Thrombolytic Therapy
- Fibrinolytic Agents
- Hemostasis
- Platelet Aggregation Inhibitors
- Thrombosis
- Summary expansion
- As the number of patients with thrombosis and thrombolysis increases, there is a critical need for clinicians to learn the latest scientific discoveries and treatment options. This timely Third Edition is a comprehensive text for cardiologists, hematologists, and pharmacologists in need of a resource on current agent development technology for treating cardiovascular and thromboembolic diseases. New to the Third Edition: a thorough examination of all the agents involved in treating thrombosis chapters on biomarkers, testing, and pharmacogenomics key topics, including new targets for antithrombotics, the development of novel classes of platelet inhibitors, new thrombolytic therapies, and evolving clinical uses of thrombolytics for ischemic stroke and venous thrombosis the hemostatic and thrombotic pathways
- Label
- New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book)
- Bibliography note
- Includes bibliographical references and index
- Carrier category
- online resource
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type MARC source
- rdacontent
- Contents
- <P><STRONG>OVERVIEW OF THE INVESTIGATION AND REGULATION AND THROMBOSIS<BR></STRONG><I>Jane EFreedman<BR></I>Overview of Hemostasis and Fibrinolysis, <I>Andrew ISchafer</I><BR>Overview of Platelet-Dependent Thrombosis, <I>Jane EFreedman, Price Blair, and Joseph Loscalzo</I><BR>Design Issues in Clinical Trials of Thrombolytic and Antithrombotic Agents, <I>Robert PGiugliano</I><BR>Pharmacogenomics and Warfarin Anticoagulation, <I>Melkon Hacobian and Samuel ZGoldhaber</I><BR>Pharmacogenomics of Platelet Inhibitors, <I>Srikanth Nagalla, Suzanne MLeal, and Paul FBray</I><BR>The Effects of Antiplatelet, Antithrombotic, and Thrombolytic Agents on Inflammation and Circulating Inflammatory Biomarkers, <I>Erdal Cavusoglu</I><BR>The Role of Platelet Function Testing in the Development of Platelet Inhibitors, <I>Alan DMichelson</I><BR>The Role of Proteomics and Transcriptomics in the Development of Antithrombotics, <I>Lisa Senzel, Dmitri VGnatenko, and Wadie FBahou<BR></I><BR><B>NEW HEPARINS, THROMBIN INHIBITORS, AND ANTITHROMBOTICS<BR></B><I>Jeffrey IWeitz<BR></I>Overview of New Anticoagulant Drugs, <I>Nahid Qushmaq and Jeffrey IWeitz</I><BR>Anticoagulants for the Treatment of Venous Thromboembolism, <I>Sam Schulman</I><BR>Anticoagulation in Acute Coronary Syndromes, <I>Simon JMcRae and John WEikelboom</I><BR>Anticoagulation in Pregnancy, <I>Shannon MBates</I><BR>Anticoagulants in Cancer, <I>Edward NLibby and Agnes YLee</I><BR>Anticoagulation in Children, <I>Paul TMonagle and Anthony K.CChan</I><BR>New Heparins: Synthetic Pentasaccharides, <I>Pieter WKamphuisen and Harry RBller</I><BR>Treatment of Heparin-Induced Thrombocytopenia, <I>Theodore EWarkentin</I><BR>Emerging Links Between Thrombosis, Inflammation, and Angiogenesis: Key Role of Heparin and Low-Molecular-Weight Heparins, <I>Shaker AMousa</I><BR>Oral Direct Factor Xa Inhibitors, <I>Alexander GGTurpie</I><BR>Direct Thrombin Inhibitors, <I>Menaka Pai and Mark ACrowther</I><BR>Modulators of the Protein C Pathway, <I>Charles TEsmon</I><BR>Factor IXa Inhibitors, <I>Richard CBecker, Mark Chan, Emily LHoward, Kristian CDBecker, and Christopher PRusconi<BR></I>Contact-Activation Pathways as Targets for New Anticoagulants, <I>David Gailani, Thomas Renne', and Andras Gruber<BR></I><BR><B>NEW ANTIPLATELET AGENTS<BR></B><I>Robert PGiugliano<BR></I>Overview of Antiplatelet Therapy, <I>Shaker AMousa, James TWillerson, and Robert PGiugliano</I><BR>Markers of Platelet Function, <I>Udaya STantry and Paul AGurbel</I><BR>Intravenous Glycoprotein IIb/IIIa Antagonists, <I>Jason NKatz and Robert AHarrington</I><BR>Inhibitors of Platelet Adhesion: VWF-GPb/IX and Collagen-GPVI<BR>Inhibitors, <I>Robert GSchaub</I><BR>Three Generations of Thienopyridines: Ticlopidine, Clopidogrel, and Prasugrel, <I>Stephen DWiviott and Elliott MAntman<BR></I>Direct PYAntagonists, <I>Marco Cattaneo</I><BR>Nitric Oxide Donors as Platelet Inhibitors, <I>Lina Badimon and Gemma Vilahur</I><BR>The Interrelationship of Thrombin and Platelets-The Protease-Activated Receptor-, <I>Rohit Bhatheja and David JMoliterno<BR></I>Other Antiplatelet Agents, <I>Catherine McGorrian and Sonia SAnand<BR></I>The Combination of Anticoagulants and Platelet Inhibitors Postcoronary Stent Implantation, <I>Hussam Hamdalla and Steven RSteinhubl<BR><BR></I><B>NEW THROMBOLYTIC AGENTS AND INDICATIONS<BR></B><I>HRoger Lijnen<BR></I>Overview of Established and New Thrombolytics, <I>HRoger Lijnen</I><BR>Thrombolysis of Deep Vein Thrombosis, <I>Peter Verhamme, Raymond Verhaeghe, and Geert Maleux</I><BR>Thrombolysis for Acute Pulmonary Embolism, <I>Gregory Piazza and Samuel ZGoldhaber</I><BR>Acute Thrombolysis in Ischemic Cerebrovascular Disease, <I>Gregory Jdel Zoppo</I><BR>Fibrinolysis for Acute Myocardial Infarction, <I>Cheuk-Kit Wong and Harvey DWhite</I><BR>Epilogue: The Evolution of Therapeutic Management of Thrombotic and Cardiovascular Disease, <I>Jane EFreedman and Joseph Loscalzo</I><BR>Index<BR></P>
- Control code
- AH24914309
- Edition
- 3rd ed.
- Extent
- xv, 690 p.
- Form of item
- electronic
- Governing access note
- After 5 minutes Preview, click on 2Request Access3, fill in a form with your details. If triggered, the book will be loaned and tied to the one user for 1 week, during which time users can read or download as they choose. 4th user request triggers auto-purchase
- Isbn
- 9781420069242
- Lccn
- 2008042440
- Media category
- computer
- Media MARC source
- rdamedia
- Specific material designation
- remote
- Label
- New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book)
- Bibliography note
- Includes bibliographical references and index
- Carrier category
- online resource
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type MARC source
- rdacontent
- Contents
- <P><STRONG>OVERVIEW OF THE INVESTIGATION AND REGULATION AND THROMBOSIS<BR></STRONG><I>Jane EFreedman<BR></I>Overview of Hemostasis and Fibrinolysis, <I>Andrew ISchafer</I><BR>Overview of Platelet-Dependent Thrombosis, <I>Jane EFreedman, Price Blair, and Joseph Loscalzo</I><BR>Design Issues in Clinical Trials of Thrombolytic and Antithrombotic Agents, <I>Robert PGiugliano</I><BR>Pharmacogenomics and Warfarin Anticoagulation, <I>Melkon Hacobian and Samuel ZGoldhaber</I><BR>Pharmacogenomics of Platelet Inhibitors, <I>Srikanth Nagalla, Suzanne MLeal, and Paul FBray</I><BR>The Effects of Antiplatelet, Antithrombotic, and Thrombolytic Agents on Inflammation and Circulating Inflammatory Biomarkers, <I>Erdal Cavusoglu</I><BR>The Role of Platelet Function Testing in the Development of Platelet Inhibitors, <I>Alan DMichelson</I><BR>The Role of Proteomics and Transcriptomics in the Development of Antithrombotics, <I>Lisa Senzel, Dmitri VGnatenko, and Wadie FBahou<BR></I><BR><B>NEW HEPARINS, THROMBIN INHIBITORS, AND ANTITHROMBOTICS<BR></B><I>Jeffrey IWeitz<BR></I>Overview of New Anticoagulant Drugs, <I>Nahid Qushmaq and Jeffrey IWeitz</I><BR>Anticoagulants for the Treatment of Venous Thromboembolism, <I>Sam Schulman</I><BR>Anticoagulation in Acute Coronary Syndromes, <I>Simon JMcRae and John WEikelboom</I><BR>Anticoagulation in Pregnancy, <I>Shannon MBates</I><BR>Anticoagulants in Cancer, <I>Edward NLibby and Agnes YLee</I><BR>Anticoagulation in Children, <I>Paul TMonagle and Anthony K.CChan</I><BR>New Heparins: Synthetic Pentasaccharides, <I>Pieter WKamphuisen and Harry RBller</I><BR>Treatment of Heparin-Induced Thrombocytopenia, <I>Theodore EWarkentin</I><BR>Emerging Links Between Thrombosis, Inflammation, and Angiogenesis: Key Role of Heparin and Low-Molecular-Weight Heparins, <I>Shaker AMousa</I><BR>Oral Direct Factor Xa Inhibitors, <I>Alexander GGTurpie</I><BR>Direct Thrombin Inhibitors, <I>Menaka Pai and Mark ACrowther</I><BR>Modulators of the Protein C Pathway, <I>Charles TEsmon</I><BR>Factor IXa Inhibitors, <I>Richard CBecker, Mark Chan, Emily LHoward, Kristian CDBecker, and Christopher PRusconi<BR></I>Contact-Activation Pathways as Targets for New Anticoagulants, <I>David Gailani, Thomas Renne', and Andras Gruber<BR></I><BR><B>NEW ANTIPLATELET AGENTS<BR></B><I>Robert PGiugliano<BR></I>Overview of Antiplatelet Therapy, <I>Shaker AMousa, James TWillerson, and Robert PGiugliano</I><BR>Markers of Platelet Function, <I>Udaya STantry and Paul AGurbel</I><BR>Intravenous Glycoprotein IIb/IIIa Antagonists, <I>Jason NKatz and Robert AHarrington</I><BR>Inhibitors of Platelet Adhesion: VWF-GPb/IX and Collagen-GPVI<BR>Inhibitors, <I>Robert GSchaub</I><BR>Three Generations of Thienopyridines: Ticlopidine, Clopidogrel, and Prasugrel, <I>Stephen DWiviott and Elliott MAntman<BR></I>Direct PYAntagonists, <I>Marco Cattaneo</I><BR>Nitric Oxide Donors as Platelet Inhibitors, <I>Lina Badimon and Gemma Vilahur</I><BR>The Interrelationship of Thrombin and Platelets-The Protease-Activated Receptor-, <I>Rohit Bhatheja and David JMoliterno<BR></I>Other Antiplatelet Agents, <I>Catherine McGorrian and Sonia SAnand<BR></I>The Combination of Anticoagulants and Platelet Inhibitors Postcoronary Stent Implantation, <I>Hussam Hamdalla and Steven RSteinhubl<BR><BR></I><B>NEW THROMBOLYTIC AGENTS AND INDICATIONS<BR></B><I>HRoger Lijnen<BR></I>Overview of Established and New Thrombolytics, <I>HRoger Lijnen</I><BR>Thrombolysis of Deep Vein Thrombosis, <I>Peter Verhamme, Raymond Verhaeghe, and Geert Maleux</I><BR>Thrombolysis for Acute Pulmonary Embolism, <I>Gregory Piazza and Samuel ZGoldhaber</I><BR>Acute Thrombolysis in Ischemic Cerebrovascular Disease, <I>Gregory Jdel Zoppo</I><BR>Fibrinolysis for Acute Myocardial Infarction, <I>Cheuk-Kit Wong and Harvey DWhite</I><BR>Epilogue: The Evolution of Therapeutic Management of Thrombotic and Cardiovascular Disease, <I>Jane EFreedman and Joseph Loscalzo</I><BR>Index<BR></P>
- Control code
- AH24914309
- Edition
- 3rd ed.
- Extent
- xv, 690 p.
- Form of item
- electronic
- Governing access note
- After 5 minutes Preview, click on 2Request Access3, fill in a form with your details. If triggered, the book will be loaned and tied to the one user for 1 week, during which time users can read or download as they choose. 4th user request triggers auto-purchase
- Isbn
- 9781420069242
- Lccn
- 2008042440
- Media category
- computer
- Media MARC source
- rdamedia
- Specific material designation
- remote
Library Links
Embed (Experimental)
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.liverpool.ac.uk/portal/New-therapeutic-agents-in-thrombosis-and/qFyqyq6_Cog/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.liverpool.ac.uk/portal/New-therapeutic-agents-in-thrombosis-and/qFyqyq6_Cog/">New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book)</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.liverpool.ac.uk/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.liverpool.ac.uk/">University of Liverpool</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Item New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book)
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.liverpool.ac.uk/portal/New-therapeutic-agents-in-thrombosis-and/qFyqyq6_Cog/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.liverpool.ac.uk/portal/New-therapeutic-agents-in-thrombosis-and/qFyqyq6_Cog/">New therapeutic agents in thrombosis and thrombolysis, edited by Jane E. Freedman, Joseph Loscalzo, (electronic book)</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.liverpool.ac.uk/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.liverpool.ac.uk/">University of Liverpool</a></span></span></span></span></div>
